Search results
Results From The WOW.Com Content Network
The Post also pointed to debate over puberty blockers in Europe, with "[m]ultiple European health authorities" reviewing scientific evidence for puberty blocker use in minors and "conclud[ing ...
Little is known about the long-term side effects of hormone or puberty blockers in children with gender dysphoria. Although puberty blockers are known to be safe and physically reversible treatment if stopped in the short term, it is also not known whether hormone blockers affect the development of factors like bone mineral density, brain ...
While the recent decision by the NHS cites a lack of research surrounding the long-term effects of puberty blockers, the treatment has been a medically accepted practice since the late 1980s ...
There are ongoing, long-term studies of puberty blockers for transgender youth, Wilson said. “Medications always have risks and benefits,” she added, “and good decision-making is based on ...
It is doubtful that a child aged 14 or 15 could understand and weigh the long-term risks and consequences of the administration of puberty blockers. In respect of young persons aged 16 and over, the legal position is that there is a presumption that they have the ability to consent to medical treatment.
No long-term results for the BATT study have been published as of yet, but a 5-year follow-up of two of the boys in the study was published and reported continued effectiveness. [148] [156] [157] [161] [154] It is intended that the study will continue until all of the boys reach adult final height, with an additional publication planned in the ...
[8] [9] In men, they are being investigated in the treatment of benign prostatic hyperplasia [10] and also as potential contraceptive agents. [11] GnRH antagonists could be used as puberty blockers in transgender youth and to suppress sex hormone levels in transgender adolescents and adults, but have not been studied in this context. [12] [13 ...
Last year the High Court ruled it was “highly unlikely” that a child aged 13 or under would be able to consent to the hormone-blocking treatment, and that it was “very doubtful” that a ...